Impact of Basophobia on Balance and Functional Outcomes in Patients With Stroke (stroke)

Impact of Basophobia on Balance and Functional Outcomes in Patients With Stroke.

Several studies have reported that the physical functions associated with falls, including motor performance, postural balance, flexibility, and muscle strength, are also associated with FoF. Patients with stroke have trouble performing ADLs, including washing their face, eating, bathing, dressing, toileting, and walking, which also affect FoF. Anxiety and depression are common affective disorders in patients with stroke and significantly increase FoF .

Study Overview

• Status: Completed
• Conditions: Stroke, Ischemic; Stroke Hemorrhagic; Balance
• Intervention / Treatment: Other: systematic desensitization and balance

Detailed Description

People who are afraid of falling because they can't keep their balance can utilize This makes them less susceptible to fall and high tendency to prevent it.

• Study Type: Observational
• Enrollment (Actual): 80
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt
    • CairoU

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Patients with stroke

Description

Inclusion Criteria:

an ischemic stroke and having had the disease for longer than three months have frequent falling, having sufficient cognition (as measured by a Montreal Cognitive Assessment score of over 26) and having upper and lower extremity spasticity ranging from (grade 1+: 2) on a modified Ashworth scale

Exclusion Criteria

) Musculoskeletal issues, such as severe arthritis, total hip arthroplasty, knee surgery, lower extremity fractures within the previous six months, or contractures brought on by a fixed deformity and/or disparity in leg length, 2) Instable medical conditions (e.g., unstable angina, recent myocardial infarction, history of congestive heart failure, major heart valve problems, or unstable hypertension);

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
basophobia in stroke patients; The study will be conducted on 80 stroke patients , will randomly assigned to one of two groups using a secure system of opaque closed envelopes as study group (GA) and control group (GB) : - -	Other: systematic desensitization and balance; Systematic desensitization: 2 techniquesJacobson's technique (progressive muscle relaxation):Guided imagery training is a relaxation technique; Goal-directed paradigm (selected program); Other Names: goal directed paradigm and balance

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Berg Balance Scale	is a five-point scaling score, a range of Zero - 4. "Zero" was given at the least level of function, while grade "4" will be given at the highest level of function. The scores are classified as follows: 41-56 = low fall risk, 21-40 = medium fall risk, and 0 -20 = high fall risk	5 months
The 16-item Fall Efficacy Scale-International	utilized to evaluate fear of falls.Varying from one (not concerned) to four (very concerned). For data analysis, the overall score, which was the sum of the 16 answers and ranged from 16 to 64 points, was utilized. A greater total score means the patients are more concerned about falling	5 months
Timed Up and Go Test (TUG)	starts with the patient getting up from the chair, walk 3 meters once a signal is given, walk 3 meters back to the chair, and then sit down calculating time taken by the patient	5 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
fear of falling	Biodex Balance Systems	5 months

Collaborators and Investigators

• Sponsor: Cairo University
• Collaborators: AlRyada University for Science & Technology
• Investigators: Study Chair: Heba Gaber, phd, ALRyada university for science and technology

Study record dates

Study Major Dates

• Study Start (Actual): September 9, 2024
• Primary Completion (Actual): March 3, 2025
• Study Completion (Actual): March 3, 2025

Study Registration Dates

• First Submitted: March 21, 2025
• First Submitted That Met QC Criteria: March 21, 2025
• First Posted (Actual): March 28, 2025

Study Record Updates

• Last Update Posted (Actual): June 18, 2025
• Last Update Submitted That Met QC Criteria: June 14, 2025
• Last Verified: June 1, 2025

More Information

Terms related to this study

• Keywords: fear of falling, balance, stroke
• Additional Relevant MeSH Terms: Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Ischemic Stroke; Hemorrhagic Stroke; Stroke
• Other Study ID Numbers: PT.BU.EC.13

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: There is not a plan to make IPD available.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No